BRNS
Price
$1.31
Change
-$0.07 (-5.07%)
Updated
Aug 6 closing price
Capitalization
52.84M
Earnings call today
NEUP
Price
$7.83
Change
-$0.01 (-0.13%)
Updated
Aug 7, 10:39 AM (EDT)
Capitalization
14.74M
Interact to see
Advertisement

BRNS vs NEUP

Header iconBRNS vs NEUP Comparison
Open Charts BRNS vs NEUPBanner chart's image
Barinthus Biotherapeutics
Price$1.31
Change-$0.07 (-5.07%)
Volume$32.49K
Capitalization52.84M
Neuphoria Therapeutics
Price$7.83
Change-$0.01 (-0.13%)
Volume$648
Capitalization14.74M
BRNS vs NEUP Comparison Chart in %
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRNS vs. NEUP commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a Buy and NEUP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (BRNS: $1.31 vs. NEUP: $7.84)
Brand notoriety: BRNS and NEUP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 2% vs. NEUP: 44%
Market capitalization -- BRNS: $52.84M vs. NEUP: $14.74M
BRNS [@Biotechnology] is valued at $52.84M. NEUP’s [@Biotechnology] market capitalization is $14.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileNEUP’s FA Score has 1 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • NEUP’s FA Score: 1 green, 4 red.
According to our system of comparison, NEUP is a better buy in the long-term than BRNS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 6 TA indicator(s) are bullish while NEUP’s TA Score has 3 bullish TA indicator(s).

  • BRNS’s TA Score: 6 bullish, 5 bearish.
  • NEUP’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BRNS is a better buy in the short-term than NEUP.

Price Growth

BRNS (@Biotechnology) experienced а -9.03% price change this week, while NEUP (@Biotechnology) price change was -3.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.67%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +14.10%.

Reported Earning Dates

BRNS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRNS($52.8M) has a higher market cap than NEUP($14.7M). NEUP YTD gains are higher at: 128.571 vs. BRNS (8.444). NEUP has higher annual earnings (EBITDA): 192K vs. BRNS (-58.89M). BRNS has more cash in the bank: 99.1M vs. NEUP (17M). NEUP has less debt than BRNS: NEUP (172K) vs BRNS (11.9M). NEUP (15.7M) and BRNS (15M) have equivalent revenues.
BRNSNEUPBRNS / NEUP
Capitalization52.8M14.7M359%
EBITDA-58.89M192K-30,673%
Gain YTD8.444128.5717%
P/E RatioN/A0.42-
Revenue15M15.7M96%
Total Cash99.1M17M583%
Total Debt11.9M172K6,919%
TECHNICAL ANALYSIS
Technical Analysis
BRNSNEUP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 22 days ago
78%
Bullish Trend 11 days ago
89%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGRPY20.440.53
+2.66%
Absa Group Ltd.
FFXDF19.100.11
+0.58%
Fairfax India Hldgs Corp
BCCEF0.03N/A
N/A
BacTech Environmental Corporation
KRIUF13.49N/A
N/A
Keg Royalties Income Fund (The)
NMKCP64.32-0.93
-1.42%
Niagara Mohawk Power Corp.

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-5.07%
SLNO - BRNS
56%
Loosely correlated
-0.54%
NGNE - BRNS
51%
Loosely correlated
-0.75%
NEUP - BRNS
50%
Loosely correlated
+3.29%
IMVT - BRNS
48%
Loosely correlated
-3.33%
TARA - BRNS
35%
Loosely correlated
-1.27%
More

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
+3.29%
SYBX - NEUP
64%
Loosely correlated
-1.43%
BRNS - NEUP
50%
Loosely correlated
-5.07%
SLGL - NEUP
42%
Loosely correlated
-2.25%
CMND - NEUP
35%
Loosely correlated
-2.03%
ENSC - NEUP
31%
Poorly correlated
-4.93%
More